Work Disability and State Benefit Claims in Early Rheumatoid Arthritis: the ERAN Cohort

Overview

Journal Rheumatology (Oxford)

Publisher Oxford University Press

Specialty Rheumatology

Date 2013 Nov 19

PMID 24241033

Citations 14

Authors

Daniel F McWilliams

Sneha Varughese

Adam Young

Patrick D Kiely

David A Walsh

Affiliations

Soon will be listed here.

Abstract

Objective: RA is an important cause of work disability. This study aimed to identify predictive factors for work disability and state benefit claims in a cohort with early RA.

Methods: The Early RA Network (ERAN) inception cohort recruited from 22 centres. At baseline, and during each annual visit, participants (n = 1235) reported employment status and benefits claims and how both were influenced by RA. Survival analysis derived adjusted hazard ratios (aHRs) and 95% CIs to predict associations between baseline factors and time until loss of employment due to RA or a state benefits claim due to RA.

Results: At baseline, 47% of participants were employed and 17% reported claiming benefits due to RA. During follow-up, loss of employment due to RA was reported by 10% (49/475) of the participants and 20% (179/905) began to claim benefits. Independent predictors of earlier work disability were bodily pain (aHR 2.45, 95% CI 1.47, 4.08, P = 0.001) and low vitality (aHR 1.84, 95% CI 1.18, 2.85, P = 0.007). Disability (aHR 1.28, 95% CI 1.02, 1.61, P = 0.033), DAS28 (aHR 1.48, 95% CI 1.05, 2.09, P = 0.026) and extra-articular disease (aHR 1.77, 95% CI 1.17, 2.70, P = 0.007) predicted earlier benefits claims.

Conclusion: Work disability and benefits claims due to RA were predicted by different baseline factors. Pain and low vitality predicted work disability. Baseline disability, extra-articular disease manifestations and disease activity predicted new benefits claims due to RA. Future research on interventions targeting these factors could investigate job retention and financial independence.

Citing Articles

Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis.

Kirkeskov L, Bray K BMC Rheumatol. 2023; 7(1):41.

PMID: 37964371 PMC: 10644429. DOI: 10.1186/s41927-023-00365-4.

Development and optimization of sustained release triptolide microspheres.

Zeng H, Qiu Q, Fu T, Deng A, Xie X PLoS One. 2023; 18(10):e0292861.

PMID: 37856525 PMC: 10586653. DOI: 10.1371/journal.pone.0292861.

Occupational impacts of early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit.

Bechman K, Cook E, Alveyn E, Houssien A, Stevens M, Russell M Rheumatology (Oxford). 2023; 63(7):1856-1867.

PMID: 37725361 PMC: 11215985. DOI: 10.1093/rheumatology/kead484.

Direct healthcare resource utilisation, health-related quality of life, and work productivity in patients with moderate rheumatoid arthritis: an observational study.

Galloway J, Edwards J, Bhagat S, Parker B, Tan A, Maxwell J BMC Musculoskelet Disord. 2021; 22(1):277.

PMID: 33714274 PMC: 7956119. DOI: 10.1186/s12891-021-04110-1.

Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider.

Marques M, Alunno A, Boonen A, Ter Wee M, Falzon L, Ramiro S RMD Open. 2021; 7(1).

PMID: 33542048 PMC: 7868290. DOI: 10.1136/rmdopen-2020-001522.

References

Gilworth G, Chamberlain M, Harvey A, Woodhouse A, Smith J, Smyth M . Development of a work instability scale for rheumatoid arthritis. Arthritis Rheum. 2003; 49(3):349-54. DOI: 10.1002/art.11114. View

Odegard S, Finset A, Kvien T, Mowinckel P, Uhlig T . Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol. 2006; 34(6):441-7. DOI: 10.1080/03009740510018633. View

de Croon E, Sluiter J, Nijssen T, Dijkmans B, Lankhorst G, Frings-Dresen M . Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2004; 63(11):1362-7. PMC: 1754825. DOI: 10.1136/ard.2003.020115. View

Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S . Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2006; 46(2):350-7. DOI: 10.1093/rheumatology/kel253. View

Kiely P, Williams R, Walsh D, Young A . Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology (Oxford). 2008; 48(1):57-60. DOI: 10.1093/rheumatology/ken406. View

Walsh D, McWilliams D . Pain in rheumatoid arthritis. Curr Pain Headache Rep. 2012; 16(6):509-17. DOI: 10.1007/s11916-012-0303-x. View

Doeglas D, Suurmeijer T, Krol B, Sanderman R, van Leeuwen M, van Rijswijk M . Work disability in early rheumatoid arthritis. Ann Rheum Dis. 1995; 54(6):455-60. PMC: 1009902. DOI: 10.1136/ard.54.6.455. View

Burton W, Morrison A, Maclean R, Ruderman E . Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond). 2005; 56(1):18-27. DOI: 10.1093/occmed/kqi171. View

Chung C, Sokka T, Arbogast P, Pincus T . Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US. Ann Rheum Dis. 2006; 65(12):1653-7. PMC: 1798477. DOI: 10.1136/ard.2005.048439. View

10.

Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Hakala M, Korpela M . Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann Rheum Dis. 2004; 64(1):130-3. PMC: 1755184. DOI: 10.1136/ard.2003.019034. View

11.

Allaire S, Wolfe F, Niu J, LaValley M, Zhang B, Reisine S . Current risk factors for work disability associated with rheumatoid arthritis: recent data from a US national cohort. Arthritis Rheum. 2009; 61(3):321-8. PMC: 2758245. DOI: 10.1002/art.24281. View

12.

Wallenius M, Skomsvoll J, Koldingsnes W, Rodevand E, Mikkelsen K, Kaufmann C . Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scand J Rheumatol. 2008; 38(3):178-83. DOI: 10.1080/03009740802400594. View

13.

Sokka T, Kautiainen H, Pincus T, Verstappen S, Aggarwal A, Alten R . Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther. 2010; 12(2):R42. PMC: 2888189. DOI: 10.1186/ar2951. View

14.

Allaire S, Anderson J, Meenan R . Reducing work disability associated with rheumatoid arthritis: identification of additional risk factors and persons likely to benefit from intervention. Arthritis Care Res. 1996; 9(5):349-57. DOI: 10.1002/1529-0131(199610)9:5<349::aid-anr1790090503>3.0.co;2-g. View

15.

Merkesdal S, Ruof J, Huelsemann J, Mittendorf T, Handelmann S, Mau W . Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data. Arthritis Rheum. 2005; 53(2):234-40. DOI: 10.1002/art.21080. View

16.

Nikiphorou E, Guh D, Bansback N, Zhang W, Dixey J, Williams P . Work disability rates in RA. Results from an inception cohort with 24 years follow-up. Rheumatology (Oxford). 2012; 51(2):385-92. DOI: 10.1093/rheumatology/ker401. View

17.

Fries J, Spitz P, Kraines R, HOLMAN H . Measurement of patient outcome in arthritis. Arthritis Rheum. 1980; 23(2):137-45. DOI: 10.1002/art.1780230202. View

18.

Verstappen S, Bijlsma J, Verkleij H, Buskens E, Blaauw A, ter Borg E . Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004; 51(3):488-97. DOI: 10.1002/art.20419. View

19.

Young A, Koduri G . Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007; 21(5):907-27. DOI: 10.1016/j.berh.2007.05.007. View

20.

Toussirot E . Predictive factors for disability as evaluated by the health assessment questionnaire in rheumatoid arthritis: a literature review. Inflamm Allergy Drug Targets. 2010; 9(1):51-9. DOI: 10.2174/187152810791292926. View